Onward Medical N.V. (EBR:ONWD)
Belgium
· Delayed Price · Currency is EUR | Market Cap | 183.21M |
| Revenue (ttm) | 2.72M |
| Net Income (ttm) | -38.65M |
| Shares Out | 44.69M |
| EPS (ttm) | -0.78 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 157,859 |
| Average Volume | 205,357 |
| Open | 4.100 |
| Previous Close | 4.100 |
| Day's Range | 4.060 - 4.185 |
| 52-Week Range | 3.495 - 7.240 |
| Beta | 0.94 |
| RSI | 42.26 |
| Earnings Date | Mar 27, 2026 |
About Onward Medical
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki... [Read more]
Financial Performance
In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.
Financial StatementsNews
Onward Medical N.V. 2025 Q3 - Results - Earnings Call Presentation
Onward Medical N.V. (ONWRF) Q3 2025 Earnings Call Transcript
Onward Medical N.V. (OTC:ONWRF) Q3 2025 Earnings Call November 24, 2025 8:00 AM ESTCompany ParticipantsSebastien Cros - Vice President of...
Onward Medical NV (ONWRF) Q3 2025 Earnings Call Highlights: Revenue Milestone and Strategic ...
Onward Medical NV (ONWRF) Q3 2025 Earnings Call Highlights: Revenue Milestone and Strategic Advancements
Q3 2025 ONWARD Medical NV Earnings Call Transcript
Q3 2025 ONWARD Medical NV Earnings Call Transcript
ONWARD Medical Secures FDA Clearance For ARC-EX System Home Use
(RTTNews) - ONWARD Medical N.V. (ONWRF, ONWDB.XD, ONWD.BR) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indication of its ARC-EX Syste...
Onward Medical Posts Preliminary Q3 Revenue Of Over EUR 1 Mln
(RTTNews) - ONWARD Medical N.V. (ONWRF, ONWDB.XD, ONWD.BR), a Dutch neuro-technology company that facilitates the patients to restore their body movement, on Monday reported a preliminary revenue of o...
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal ...
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe | ONWRY Stock News
Onward Medical N.V. (ONWRF) Q2 2025 Earnings Call Transcript
Onward Medical N.V. 2025 Q2 - Results - Earnings Call Presentation
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its ...
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors | ONWRY Stock News